|
|
Office Locations:
|
999 Baker Way, Ste 120
San Mateo, CA 94404
Phone: 650-591-9102
Fax: 650-591-1328
| |
|
|
|
|
|
|
Energy & Clean Tech
Life Sciences & Healthcare
Media & Digital Media
Medical Device
|
|
|
|
EDBI, the investment arm of the Singapore Economic Development Board, is a leading investment management company for biomedical sciences in Asia. With a global presence through offices in the U.S. and Europe, EDBI plays a role as a business and scientific bridge between biomedical companies in Singapore, Asia, U.S. and Europe. EDBI manages $790 million in funds and invests in promising biotechnology, specialty pharmaceuticals, and medical technology companies and start-ups to facilitate the growth of a vibrant biomedical sciences industry in Singapore. EDBI is actively investing its fourth fund, Biomedical Sciences Investments Fund (BMSIF). The firm's primary areas of interest are: therapeutics and therapeutic services, medical technology and healthcare services. For 30 years, EDBI has provided support and access to companies across key focus areas.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
